AlphaYouMB
Insider selling
Matthias Bodenstedt sold $273K of MoonLake Immunotherapeutics (MLTX) stock
Matthias Bodenstedt, Chief Financial Officer of MoonLake Immunotherapeutics (MLTX), sold 13,653 shares of MLTX stock worth $273K, per an SEC Form 4 filed May 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 11, 2026, 2 days before it was made public.
MLTX has moved -33.4% since the trade date, from $18.84 to $12.55 (Sep 21, 2026 close).
- Traded
- May 11, 2026
- Disclosed
- May 13, 2026
- Filing delay
- 2 days
- Price since
- -33.4%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More MLTX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.